HCA Healthcare (HCA) EBIT (2010 - 2026)

HCA Healthcare has disclosed EBIT across 17 years of filings, most recently posting -$566.0 million for Q1 2026.

• In Q1 2026, EBIT rose 62.71% year-over-year to -$566.0 million; the TTM figure through Mar 2026 stood at -$7.6 billion (up 19.89% YoY), while the FY2025 annual figure was $2.1 billion, up 15.36% from the prior year.
• EBIT improved to -$566.0 million in Q1 2026, from -$4.8 billion in the prior quarter.
• Over the last five years, EBIT for HCA reached as high as -$424.0 million in Q1 2024 and fell as low as -$4.8 billion in Q4 2025.
• The 5-year median for EBIT is -$972.0 million (2023), against an average of -$1.6 billion.
• Annual changes were most pronounced in 2022 — EBIT tumbled 272.21% — and 2025, when it jumped 69.05%.
• A 5-year view of EBIT shows it stood at -$911.0 million in 2022, then plunged by 252.58% to -$3.2 billion in 2023, then plunged by 47.07% to -$4.7 billion in 2024, then declined by 2.12% to -$4.8 billion in 2025, then jumped by 88.27% to -$566.0 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$566.0 million, -$4.8 billion, and -$1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.